Editorial

Nuclear Medicine Communications

Volumn 22, Issue 6, 2001, Pages 607-611

  Petretta, M ^a   Acampa, W ^a   Cuocolo, A ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GLUCOSE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; RADIOISOTOPE; TETROFOSMIN TC 99M; THALLIUM 201;

CORONARY ARTERY DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; EDITORIAL; GATED IMAGING; GLUCOSE METABOLISM; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE BLOOD FLOW; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; MYOCARDIAL HIBERNATION; PATIENT SELECTION; POSITRON EMISSION TOMOGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STUNNED HEART MUSCLE; TREATMENT OUTCOME;

HEART; HUMANS; MYOCARDIAL ISCHEMIA; RADIOPHARMACEUTICALS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0034993345     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/00006231-200106000-00001     Document Type: Editorial

References (38)

1. Rahimtoola SH. The hibernating myocardium. Am Heart J 1989; 117: 211-221.
2. Rahimtoola SH. A perspective on the three large multicenter randomized clinical trials of coronary by-pass surgery for chronic stable angina. Circulation 1985; 72: V123-V135.
3. Ross Jr J. Myocardial perfusion-contraction matching. Implication for coronary heart disease and hibernation. Circulation 1991; 83: 1076-1083.
4. Sun KT, Czernin J, Krivokapich J, et al. Effects of dobutamine stimulation on myocardial blood flow, glucose metabolism, and wall motion in normal and dysfunctional myocardium. Circulation 1996; 94: 3146-3154.
5. Vanoverschelde JJ, Wijns W, Borges M, et al. Chronic myocardial hibernation in humans. From bedside to bench. Circulation 1997; 95: 1961-1971.
6. Bonow RO, Dilsizian V. Assessing viable myocardium with thallium-201. Am J Cardiol 1992; 70: 10E-17E.
7. Dilsizian V, Rocco TP, Freedman NMT, Leon MB, Bonow RO. Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging. N Engl J Med 1990; 323: 141-146.
8. Ragosta M, Beller GA, Watson DD, Kaul S, Gimple LW. Quantitative planar rest-redistribution Tl-201 imaging in detection of myocardial viability and prediction of improvement in left ventricular function after coronary artery bypass surgery in patients with severely depressed left ventricular function. Circulation 1993; 87: 1630-1641.
9. Petretta M, Cuocolo A, Bonaduce D, et al. Incremental prognostic value of thallium reinjection after stress-redistribution imaging in patients with previous myocardial infarction and left ventricular dysfunction. J Nucl Med 1997; 38: 195-199.
10. Petretta M, Cuocolo A, Bonaduce D, et al. Prognostic value of coronary angiography in patients with chronic ischemic left ventricular dysfunction and evidence of viable myocardium on thallium reinjection imaging. J Nucl Cardiol 1997; 4: 387-395.
11. Holman ML, Moore SC, Shulkin PM, Kirsch CM, English RJ, Hill TC. Quantification of perfused myocardial mass through thallium-201 and emission computed tomography. Invest Radiol 1983; 4: 322-326.
12. Pagley PR, Beller GA, Watson DD, Gimple LW, Ragosta M. Improved outcome after coronary bypass surgery in patients with ischemic cardiomyopathy and residual myocardial viability. Circulation 1997; 96: 793-800.
13. Cuocolo A, Nicolai E, Petretta M, et al. One-year effect of myocardial revascularization on resting left ventricular function and regional thallium uptake in chronic CAD. J Nucl Med 1997; 38: 1684-1692.
14. Cuocolo A, Petretta M, Nicolai E, et al. Successful coronary revascularization improves prognosis in patients with previous myocardial infarction and evidence of viable myocardium at thallium-201 imaging. Eur J Nucl Med 1998; 25: 60-68.
15. Beanlands RSB, Dawood F, Wen WH, et al. Are the kinetics of technetium 99m-methoxy isobutyl isonitrile affected by cell metabolism and viability? Circulation 1990; 82: 1802-1814.
16. Sinusas AJ, Bergin JD, Edwards NC, et al. Redistribution of Tc-99m sestamibi and Tl-201 in the presence of a severe coronary artery stenosis. Circulation 1994; 89: 2332-2341.
17. Maes AF, Borges M, Flameng W, et al. Assessment of myocardial viability in chronic coronary artery disease using technetium-99 sestamibi SPECT. Correlation with histologic and positron emission tomographic studies and functional follow-up. J Am Coll Cardiol 1997; 29: 62-69.
18. Matsunari I, Fujino S, Taki J, et al. Quantitative rest technetium-99m tetrofosmin imaging in predicting functional recovery after revascularization: comparison with rest-redistribution thallium-201. J Am Coll Cardiol 1997; 29: 1226-1232.
19. Cuocolo A, Acampa W, Nicolai E, et al. Quantitative thallium-201 and technetium-99m sestamibi tomography at rest in detection of myocardial viability and prediction of improvement in left ventricular function after coronary revascularization in patients with chronic ischemic left ventricular dysfunction. J Nucl Cardiol 2000; 7: 8-15.
20. Bax JJ, Wijns W, Cornel JH, Visser FC, Fioretti PM. Accuracy of currently available techniques for prediction of functional recovery after revascularization in patients with left ventricular dysfunction due to chronic coronary artery disease. Comparison of pooled data. J Am Coll Cardiol 1997; 30: 1451-1460.
21. Maurea S, Cuocolo A, Soricelli A, et al. Enhanced detection of viable myocardium by technetium-99m MIBI imaging after nitrate administration in chronic coronary artery disease. J Nucl Med 1995; 36: 1945-1952.
22. Bisi G, Sciagrà R, Santoro GM, et al. Sublingual isosorbide dinitrate to improve technetium-99m-teboroxime perfusion defect reversibility. J Nucl Med 1994; 35: 1274-1278.
23. Bisi G, Sciagrà Santoro GM, et al. Technetium-99m-sestamibi imaging with nitrate infusion to detect viable hibernating myocardium and predict postrevascularization recovery. J Nucl Med 1995; 36: 1994-2000.
24. Brown BG, Bolson E, Peterson RB, Pierce CD, Dodge HT. The mechanisms of nitroglycerin action: stenosis vasodilation as a major component of the drug response. Circulation 1981; 64: 1089-1097.
25. Fujita M, Yamanishi K, Hirai T, et al. Significance of collateral circulation in reversible left ventricular asynergy by nitroglycerin in patients with relatively recent myocardial infarction. Am Heart J 1990; 120: 521-528.
26. Rafflenbeul W, Urthaler F, O’Russel R, et al. Dilatation of coronary artery stenoses after isosorbide dinitrate in man. Br Heart J 1980; 43: 546-549.
27. Greco C, Ciavolella M, Tanzilli G, et al. Preoperative identification of viable myocardium: effectiveness of nitroglycerin-induced changes in myocardial sestamibi uptake. Cardiovasc Surg 1998; 6: 149-155.
28. Oudiz R, Smith D, Pollack A, et al. Nitrate-enhanced thallium-201 single-photon emission computed tomographic imaging in hibernating myocardium. Am Heart J 1999; 138: 369-375.
29. Sias TM, Watson DD, Beller GA. Is nitroglycerin useful for the enhancement of viability detection with myocardial perfusion imaging? Am Heart J 1999; 138: 206-209.
30. He ZX, Verani MS. Evaluation of myocardial viability by myocardial perfusion imaging: should nitrates be used? J Nucl Cardiol 1998; 5: 527-532.
31. Fagret D, Marie PY, Brunotte F, et al. Myocardial perfusion imaging with technetium-99m-NOET. Comparison with thallium-201 and coronary angiography. J Nucl Med 1995; 36: 936-943.
32. Borges-Neto S, Shaw LK. The added value of simultaneous myocardial perfusion and left ventricular function. Curr Opin Cardiol 1999; 14: 460-463.
33. Beller GA, Ragosta M. Extent of myocardial viability in regions of left ventricular dysfunction by rest-redistribution thallium-201 imaging. A powerful predictor of outcome. J Nucl Cardiol 1998; 5: 445-448.
34. Petretta M, Cuocolo A, Nicolai E, Acampa W, Salvatore M, Bonaduce D. Combined assessment of left ventricular function and rest-redistribution regional myocardial thallium-201 activity for prognostic evaluation of patients with chronic coronary artery disease and left ventricular dysfunction. J Nucl Cardiol 1998; 5: 378-386.
35. Pagley PR, Beller GA, Watson DD, Gimple LW, Ragosta M. Improved outcome after coronary bypass surgery in patients with ischemic cardiomyopathy and residual myocardial viability. Circulation 1997; 96: 793-800.
36. Srinivasan G, Kitsiou AN, Bacharach SL, Barlett ML, Miller-Davis C, Dilsizian V. (F-18)-Fluorodeoxyglucose single photon emission computed tomography: can it replace PET and thallium SPECT for the assessment of myocardial viability? Circulation 1998; 97: 843-850.
37. Bax JJ, Cornel JH, Visser FC, et al. Prediction of recovery of myocardial dysfunction after revascularization: Comparison of fluorine-18 fluorodeoxyglucose/thallium-201 stress-reinjection SPECT and dobutamine echocardiography. J Am Coll Cardiol 1996; 28: 558-564.
38. Sato H, Iwasaki T, Toyama T, et al. Prediction of functional recovery after revascularization in coronary artery disease using (18)F-FDG and (123)I-BMIPP SPECT. Chest 200; 117: 65-72.